World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
32686
World Ranking
16922
National Ranking
8489

Sydney E. Salmon publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Sydney E. Salmon sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 279 publications — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Sydney E. Salmon D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Sydney E. Salmon sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 80 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Sydney E. Salmon was affiliated with the University of Arizona in the United States. Their academic contributions extended through various aspects of scientific research during their career.

No specific details about their recent papers, including titles, years of publication, or publication venues, are available. Similarly, there is no recorded information on frequent co-authors or regular publication venues related to their research outputs.

Details about the scientist's engagement in book publications were not provided, thus no data on publishers or the number of books authored is known.

The main fields and subfields of study they focused on have not been documented, and there are no listed specific topics that characterize their research interests. Likewise, no awards or honors have been recorded in connection with their work.

As Sydney E. Salmon is deceased, the account of their career and contributions is presented in the past tense to reflect their completed professional journey.

Best Publications

  • A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

    Brian G. M. Durie;Sydney E. Salmon

  • Primary bioassay of human tumor stem cells

    Sydney E. Salmon;Anne W. Hamburger

  • A new type of synthetic peptide library for identifying ligand-binding activity

    Kit S. Lam;Sydney E. Salmon;Evan M. Hersh;Victor J. Hruby

  • Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

    Robert C. Flanigan;Sydney E. Salmon;Brent A. Blumenstein;Scott I. Bearman

  • Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer Drugs

    Sydney E. Salmon;Anne W. Hamburger;Barbara Soehnlen;Brian G. M. Durie

  • Evidence for the secretion of an osteoclast stimulating factor in myeloma.

    Gregory R. Mundy;Lawrence G. Raisz;Robert A. Cooper;Geraldine P. Schechter

  • Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma.

    Bart Barlogie;Sundar Jagannath;David H. Vesole;Sally Naucke

  • Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof

    Kit Sang Lam;Sydney E. Salmon;Victor J. Hruby;Evan M. Hersh

  • Primary Bioassay of Human Myeloma Stem Cells

    Anne Hamburger;Sydney E. Salmon

  • Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

    W. S. Dalton;T. M. Grogan;P. S. Meltzer;R. J. Scheper

  • P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil.

    Thomas P. Miller;Thomas M. Grogan;William S. Dalton;Catherine M. Spier

  • Dose response evaluation of adriamycin in human neoplasia

    R. M. O'Bryan;L. H. Baker;J. E. Gottlieb;S. E. Rivkin

  • Pretreatment tumor mass, cell kinetics, and prognosis in multiple myeloma.

    Brian G.M. Durie;Sydney E. Salmon;Thomas E. Moon

  • Maintenance therapy with alternate-day prednisone improves survival in multiple myeloma patients

    James R. Berenson;John J. Crowley;Thomas M. Grogan;Jeffrey Zangmeister

  • Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer.

    Sydney E. Salmon;William S. Dalton;Thomas M. Grogan;Patricia Plezia

  • Kinetics of tumor growth and regression in IgG multiple myeloma

    Peter W. Sullivan;Sydney E. Salmon

  • Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer.

    Stephen E. Jones;Brian G. M. Durie;Sydney E. Salmon

  • Immunohistochemical detection and quantitation of p-glycoprotein in multiple drug-resistant human myeloma cells: association with level of drug resistance and drug accumulation

    William S. Dalton;Thomas M. Grogan;James A. Rybski;Rik J. Scheper

  • Polyamines as Markers of Response and Disease Activity in Cancer Chemotherapy

    Brian G. M. Durie;Sydney E. Salmon;Diane H. Russell

  • Recombinant Human Erythropoietin Therapy for Anemic Cancer Patients on Combination Chemotherapy

    Delvyn C. Case;Ronald M. Bukowski;Robert W. Carey;Ellioth H. Fishkin

Frequent Co-Authors

David S. Alberts
David S. Alberts University of Arizona
Brian G.M. Durie
Brian G.M. Durie Cedars-Sinai Medical Center
William S. Dalton
William S. Dalton University of South Florida
Victor J. Hruby
Victor J. Hruby University of Arizona
Kit S. Lam
Kit S. Lam University of California, Davis
Frank L. Meyskens
Frank L. Meyskens University of California, Irvine
Thomas M. Grogan
Thomas M. Grogan Roche (Switzerland)
Thomas P. Miller
Thomas P. Miller University of Arizona
John Crowley
John Crowley Washington University in St. Louis
Bart Barlogie
Bart Barlogie Mount Sinai Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The landscape of medical and healthcare education in the USA is rapidly evolving, with many students looking beyond traditional pathways. Online degree programs offer flexible opportunities, allowing you to study while balancing work or family commitments. For example, nurses seeking career advancement can consider the best online dnp programs to prepare for leadership roles in healthcare organizations.

If you’re interested in pharmacy, opportunities exist to complete a 3 year online pharmd program, allowing practitioners to advance their qualifications efficiently. Additionally, those who wish to work in health information management—a fast-growing, tech-focused field—can explore options like an online bachelor's in health information management.

For individuals seeking to quickly enter the healthcare workforce, medical billing and coding programs are a popular choice. It's important to research the average cost of medical billing and coding program to ensure affordability. These online career pathways can provide a more accessible route into the broad field of healthcare.

Best Scientists Citing Sydney E. Salmon

Recently Published Articles